Jos H.M. Lange, Chris G. Kruse
文献索引:Drug Discov. Today 10 , 693-702, (2005)
全文:HTML全文
The proven clinical efficacy of the CB1 cannabinoid receptor antagonist rimonabant in obesity and its further therapeutic potential has given a tremendous impetus to the discovery of novel CB1 antagonists.